Small molecule discovery offers hope for treatment of Angelman syndrome

FHS
July 8, 2024
12:39 pm

Angelman syndrome is a rare genetic disorder caused by mutations in the maternally-inherited UBE3A gene and characterized by poor muscle control, limited speech, epilepsy, and intellectual disabilities.

Mediktor Acquires Conversational AI Platform Sensely

From left to right – Adam Odessky and Cristian Pascual What You Should Know: – Mediktor, a provider of AI-powered healthcare solutions, announced today the

June 6, 2024

Algernon Pharmaceuticals Announces Increase to Private Placement | Psychedelic Invest

Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW0) (OTCQB: AGNPF) (the “Company” or “Algernon”) a Canadian clinical stage pharmaceutical development company announces an increase to its non-brokered

January 2, 2024

Biophytis extends its contract with Atlas to secure financing for its business activities – Biotech Investments

Biophytis / Key word(s): Miscellaneous/Miscellaneous Biophytis extends its contract with Atlas to secure financing for its business activities 20-Jun-2024 / 01:10 CET/CEST Biophytis extends its

June 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.